Efficacy, safety, tolerability and pharmacokinetics of a novel human immune globulin subcutaneous, 20%: a Phase 2/3 study in Europe in patients with primary immunodeficiencies
Borte, M., Kriván, G., Derfalvi, B., Maródi, L., Harrer, T., Jolles, S., Bourgeois, C., Engl, W., Leibl, H., McCoy, B., Gelmont, D., Yel, L.
Published in Clinical and experimental immunology (01.01.2017)
Published in Clinical and experimental immunology (01.01.2017)
Get full text
Journal Article
P252 Results of a phase 2/3 study of SCIG 20% in PIDD patients in North America
Suez, D, Melamed, I, Hussain, I, Stein, M, Gupta, S, Paris, K, Bourgeois, C, Leibl, H, McCoy, B, Yel, L
Published in Annals of allergy, asthma, & immunology (01.11.2016)
Published in Annals of allergy, asthma, & immunology (01.11.2016)
Get full text
Journal Article
Rapid subcutaneous immunoglobulin administration every second week results in high and stable serum immunoglobulin G levels in patients with primary antibody deficiencies
Gustafson, R, Gardulf, A, Hansen, S, Leibl, H, Engl, W, Lindén, M, Müller, A, Hammarström, L
Published in Clinical and experimental immunology (01.05.2008)
Published in Clinical and experimental immunology (01.05.2008)
Get full text
Journal Article
P254 Local adverse reactions decreased over time during IGHY treatment in patients with PIDD
Stein, M, Wasserman, R, Melamed, I, Gupta, S, Kobrynski, L, Rubinstein, A, Rabbat, C, Engl, W, McCoy, B, Leibl, H, Yel, L
Published in Annals of allergy, asthma, & immunology (01.11.2016)
Published in Annals of allergy, asthma, & immunology (01.11.2016)
Get full text
Journal Article
P253 Safety and tolerability of SCIG 20% in patients with PIDD in europe and north america
Suez, D, Krivan, G, Derfalvi, B, Hussain, I, Stein, M, Gupta, S, Paris, K, Brodszki, N, Leibl, H, McCoy, B, Yel, L
Published in Annals of allergy, asthma, & immunology (01.11.2016)
Published in Annals of allergy, asthma, & immunology (01.11.2016)
Get full text
Journal Article
Pharmacokinetics (PK) of Human Immunoglobulin 10% (IgG) Administered Intravenously (IGIV), Subcutaneously (IGSC) or Facilitated Subcutaneously with Recombinant Human Hyaluronidase (IGHy) in a Subset of Patients with Primary Immunodeficiency Disease (PIDD)
Stein, M, Wasserman, R.L, Melamed, I, Puck, J, Gupta, S, Engl, W, Leibl, H, Gelmont, D, Schiff, R.I
Published in Journal of allergy and clinical immunology (01.02.2012)
Published in Journal of allergy and clinical immunology (01.02.2012)
Get full text
Journal Article
Tolerability and Efficacy of Facilitated-Subcutaneous Infusion of Immune Globulin (Human), 10% and Recombinant Human Hyaluronidase (IGHy) in a Subset of Study Patients With Primary Immunodeficiency Disease (PIDD)
Wasserman, R.L, Melamed, I, Stein, M, Puck, J, Gupta, S, Engl, W, Leibl, H, Gelmont, D, Schiff, R.I
Published in Journal of allergy and clinical immunology (01.02.2012)
Published in Journal of allergy and clinical immunology (01.02.2012)
Get full text
Journal Article
Safety and Pharmacokinetics of Facilitated-Subcutaneous Infusion of Immune Globulin (Human), 10% and Recombinant Human Hyaluronidase (IGHy) in a Phase III Extension Study in Patients With Primary Immunodeficiency Disease (PIDD)
Melamed, I, Wasserman, R.L, Stein, M, Puck, J, Gupta, S, Engl, W, Leibl, H, Gelmont, D, Schiff, R.I
Published in Journal of allergy and clinical immunology (01.02.2012)
Published in Journal of allergy and clinical immunology (01.02.2012)
Get full text
Journal Article
Efficacy Analysis of Immune Globulin Subcutaneous (Human), 10% (IGSC) Administered Intravenously or Subcutaneously in Subjects with Primary Immunodeficiency Diseases (PIDD)
Schiff, R.I, Wasserman, R.L, Melamed, I, Stein, M, Engl, W, Leibl, H, Gelmont, D, Grossman, W.J
Published in Journal of allergy and clinical immunology (01.02.2011)
Published in Journal of allergy and clinical immunology (01.02.2011)
Get full text
Journal Article
Tolerability of Human Immunoglobulin 10% Administered Subcutaneously Following Administration of Recombinant Human Hyaluronidase (rHuPH20) in Primary Immunodeficiency Disease (PIDD) Patients
Gelmont, D, Wasserman, R.L, Melamed, I, Stein, M, Rubinstein, A, McCoy, B, Engl, W, Leibl, H, Schiff, R.I, Grossman, W.J
Published in Journal of allergy and clinical immunology (01.02.2011)
Published in Journal of allergy and clinical immunology (01.02.2011)
Get full text
Journal Article
New Immune Globulin Subcutaneous (Human), 10% (IGSC) Product is Well Tolerated in Subjects with Primary Immunodeficiency Diseases (PIDD)
Grossman, W.J, Wasserman, R.L, Melamed, I, Stein, M, Engl, W, Leibl, H, Schiff, R.I, Gelmont, D
Published in Journal of allergy and clinical immunology (01.02.2011)
Published in Journal of allergy and clinical immunology (01.02.2011)
Get full text
Journal Article
Pharmacokinetic Analysis (PK) of Immune Globulin Subcutaneous (Human), 10% (IGSC) Administered Intravenously or Subcutaneously in Subjects with Primary Immunodeficiency Diseases (PIDD)
Leibl, H, Wasserman, R.L, Melamed, I, Stein, M, Engl, W, Schiff, R.I, Gelmont, D, Grossman, W.J
Published in Journal of allergy and clinical immunology (01.02.2011)
Published in Journal of allergy and clinical immunology (01.02.2011)
Get full text
Journal Article
Pharmacokinetics (PK) of Human Immunoglobulin 10% Administered Subcutaneously Alone or Following Recombinant Human Hyaluronidase (rHuPH20) in Primary Immunodeficiency Disease (PIDD) Patients
Rubinstein, A, Wasserman, R.L, Melamed, I, Stein, M, McCoy, B, Engl, W, Leibl, H, Gelmont, D, Schiff, R.I, Grossman, W.J
Published in Journal of allergy and clinical immunology (01.02.2011)
Published in Journal of allergy and clinical immunology (01.02.2011)
Get full text
Journal Article
IGIV-10% Infused Intravenously And Subcutaneously To Subjects With Primary Immunodeficiency Diseases - Comparison Of Pharmacokinetic Properties
Leibl, H, Engl, W, Melamed, I, Stein, M, Wasserman, R.L, Berger, M, Schiff, R.I
Published in Journal of allergy and clinical immunology (01.02.2009)
Published in Journal of allergy and clinical immunology (01.02.2009)
Get full text
Journal Article
Prospective open-label study of pharmacokinetics, efficacy and safety of a new 10% liquid intravenous immunoglobulin in patients with hypo- or agammaglobulinemia
Björkander, J., Nikoskelainen, J., Leibl, H., Lanbeck, P., Wallvik, J., Lumio, J. T., Braconier, J. H., Pavlova, B. G., Birthistle, K., Engl, W., Walter, S., Ehrlich, H. J.
Published in Vox sanguinis (01.05.2006)
Published in Vox sanguinis (01.05.2006)
Get full text
Journal Article
Recombinant Human Hyaluronidase Facilitates Dispersion of Subcutaneously Administered Gammagard Liquid and Enables Administration of a Full Monthly Dose in a Single Site to Patients with Immunodeficiency Diseases
Melamed, I.R, Stein, M.R, Wasserman, R.L, Leibl, H, Engl, W, Yocum, R.C, Schiff, R.I
Published in Journal of allergy and clinical immunology (01.02.2008)
Published in Journal of allergy and clinical immunology (01.02.2008)
Get full text
Journal Article
Efficacy, safety and tolerability of a new intravenous immune globulin, 10% liquid, triple virus reduced (IGIV,10%TVR) in patients with primary immunodeficiency (PID)
Church, J.A., Leibl, H., Stein, M.R., Melamed, I.R., Rubinstein, A., Schneider, L.C., Wasserman, R.L., Pavlova, B.G., Birthistle, K., Mancini, M., Bitman, B., Moore-Perry, K., Ehrlich, H.J.
Published in Journal of allergy and clinical immunology (01.02.2005)
Published in Journal of allergy and clinical immunology (01.02.2005)
Get full text
Journal Article
P279 Post-authorization safety study of hyaluronidase-facilitated subcutaneous immunoglobulin 10% treatment in patients with primary immunodeficiency diseases
Rubinstein, A., Bridges, T., McNeil, D., Tachdjian, R., Wedner, H., Wasserman, R., Leibl, H., Rabbat, C., Honigberg, R., Yel, L.
Published in Annals of allergy, asthma, & immunology (01.11.2017)
Published in Annals of allergy, asthma, & immunology (01.11.2017)
Get full text
Journal Article
Affinity Binding of Distinct Functional Fibronectin Domains to Immobilized Metal Chelates
Gmeiner, B., Leibl, H., Zerlauth, G., Seelos, C.
Published in Archives of biochemistry and biophysics (01.08.1995)
Published in Archives of biochemistry and biophysics (01.08.1995)
Get full text
Journal Article